A Study to Determine the Safety and Efficacy of TG-C in Subjects With Kellgren and Lawrence Grade 2 or 3 OA of the Knee
Clinical trial NCT03203330 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03203330
- Sponsor
- Kolon TissueGene, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-30
- Primary completion
- 2024-07-10
- Enrollment
- 535
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.